Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02743312
Other study ID # X15-48a
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 2015
Est. completion date June 2016

Study information

Verified date October 2018
Source San Francisco State University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this pilot study is to test the protocol for investigating the longer-term effects of torso weighting on physical activity, number of falls, and muscle activation (when muscles turn on and off and how intensely) in five volunteers with multiple sclerosis. The hypotheses of this study include: torso weighting will (1) increase physical activity, (2) decrease the number of falls, and (3) improve the timing and coordination of muscle activation during balance perturbations.


Description:

Torso weighting, using the balance-based torso-weighting (BBTW) method, is an intervention that addresses balance by first challenging stability in standing using a series of perturbations (nudges) and resisted rotations to people. Challenging stability allows the assessor to determine directional instability. Once the direction of instability is determined, small weights are placed on a vest-like garment and retesting of balance occurs. In this study, participants will be tested with no weights (NW), with sham weights (SW), and with BBTW weighting (WT). Following non-weighted baseline assessment, participants will be randomly allocated into the sham weight condition or BBTW weight condition in a cross-over design. The initial condition (NW) will last four weeks and the final two conditions (SW,WT) will last two weeks each. Following each condition, outcome measures will be reassessed. Throughout the study, participants will be asked to wear a commercially-available remote monitoring device (e.g., Fitbit Flex) and keep a daily log of physical activity and number of falls. During the SW and WT conditions, participants will wear the assigned garment for 2-4 hours daily.


Recruitment information / eligibility

Status Completed
Enrollment 5
Est. completion date June 2016
Est. primary completion date May 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Self-reported a diagnosis of multiple sclerosis

- Self-reported mild or moderate gait or balance difficulties

- Living in the community rather than in a care facility

- Able to walk independently for at least one minute at a time with or without an assistive device

- No exacerbations within the past 2 months

- Able to get to the testing area and tolerate 2-3 hours of testing for each assessment occasion

- Willing to be nudged by a researcher when standing

Exclusion Criteria:

- Unable to comprehend and follow instructions in English

- Current diagnosis of other neurological disorders such as head injury, stroke, Parkinson disease, or other conditions that affect gait or balance (self-reported)

- Experiencing pain that could be exacerbated by external perturbation while standing

- History of skin reaction to adhesives

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Torso Weights
Following assessment of an individual's directional instability, small weights are applied to a vest-like garment to correct balance loss.
Sham Weights
Following assessment of an individual's directional instability, small weights are applied to a vest-like garment to correct balance loss. The garment is then taken by another investigator and the actual weights are replaced with sham weights.
Fitbit Flex
Potential effect on participants' physical activity to see their own step count using this wrist-worn remote monitoring device.

Locations

Country Name City State
United States Samuel Merritt University, Motion Analysis Research Center Oakland California

Sponsors (2)

Lead Sponsor Collaborator
San Francisco State University Samuel Merritt University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Steps Per Day Continuous activity data collection via commercially-available remote monitoring device and stored on server. up to 8 weeks
Secondary Sensory Organization Test balance tested during 6 conditions on Neuro-com forceplate and surround and reported as a composite score (across the six conditions), 0-100, with higher scores indicating better balance; measure reported reflects change in the composite score from the visit that initiates Torso-weighting (TW) or sham weights (SW) to the visit that concludes daily wearing of TW or SW change from initiation to 2-weeks after initiation of daily wearing of TW or SW
Secondary Gait Velocity As measured using instrumented gait mat. change from initiation to 2-weeks after initiation of daily wearing of TW or SW
Secondary Movement Ability Measure, Computer Adaptive Test Version (MAM-CAT) Online self-report of perceived current movement ability and preferred movement ability. The scores are reported in standardized logits, 0-6, where 6 is competitive level athletic movement. The reported values are the average change in current movement ability from initiation of daily wear to after 2 weeks of daily wear of TW or SW. change from initiation to 2-weeks after initiation of daily wearing of TW or SW
Secondary Activities-Specific Balance Confidence Scale Self-report measure of perception of confidence under various balance challenges on a scale of 0-100 with 100 being fully confident that the individual can perform the listed balance challenge without falling. Data reported reflect the difference in scores from initiation to the 2-week point after initiation of TW or SW. change from initiation to 2-weeks after initiation of daily wearing of TW or SW
Secondary Multiple Sclerosis Impact Scale 29 Self-report measure of the impact of MS on activities and participation. The scale is reported in a physical and psychological subscale, with higher numbers (out of 100) indicating worse impact of multiple sclerosis (MS) on function. Data are reported as change from initiation of TW or SW to end of 2 weeks of daily wear. change from initiation to 2-weeks after initiation of daily wearing of TW or SW
Secondary Multiple Sclerosis Walking Scale 12 Self-report measure of the effect of MS on walking ability. Larger numbers out of 100 mean that MS limits walking much more. Data are reported as change in score from initiation of TW or SW to the visit after 2 weeks of daily wear of TW or SW. change from initiation to 2-weeks after initiation of daily wearing of TW or SW
Secondary Six-Minute Walk Test distance participant walks in 6 minutes. Larger numbers indicate more distance covered. Data reported are the change in distance walked from initiation of TW or SW to after 2 weeks of daily wear. change from initiation to 2-weeks after initiation of daily wearing of TW or SW
Secondary Stride Length As measured using instrumented gait mat. change from initiation to 2-weeks after initiation of daily wearing of TW or SW
Secondary Percent of Gait Cycle in Single Limb Support As measured in percent (e.g., 0.35) of gait cycle spent on one limb using instrumented gait mat. change from initiation to 2-weeks after initiation of daily wearing of TW or SW
Secondary Step Width As measured using instrumented gait mat. change from initiation to 2-weeks after initiation of daily wearing of TW or SW
Secondary Electromyography to Assess Muscle Activation Recording of muscle activation during quiet and perturbed standing before and after intervention at weeks 4, 6, and 8. Average values with and without weighting during each visit. Week 4, Week 6, Week 8
Secondary Number of Falls Recorded in 2 Weeks of Wear Time. Daily log manually recorded by participant for the 2 weeks of wear time. This is a descriptive measure recording the total count (number) of falls per arm. count of number of falls recorded at the end of two weeks of wearing TW or SW
See also
  Status Clinical Trial Phase
Completed NCT05528666 - Risk Perception in Multiple Sclerosis
Completed NCT03608527 - Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis N/A
Recruiting NCT05532943 - Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis Phase 1/Phase 2
Completed NCT02486640 - Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
Completed NCT01324232 - Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Phase 2
Completed NCT04546698 - 5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
Active, not recruiting NCT04380220 - Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
Completed NCT02835677 - Integrating Caregiver Support Into MS Care N/A
Completed NCT03686826 - Feasibility and Reliability of Multimodal Evoked Potentials
Recruiting NCT05964829 - Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis N/A
Withdrawn NCT06021561 - Orofacial Pain in Multiple Sclerosis
Completed NCT03653585 - Cortical Lesions in Patients With Multiple Sclerosis
Recruiting NCT04798651 - Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis N/A
Active, not recruiting NCT05054140 - Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis Phase 2
Completed NCT05447143 - Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis N/A
Recruiting NCT06195644 - Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients Phase 1
Completed NCT04147052 - iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis N/A
Completed NCT03594357 - Cognitive Functions in Patients With Multiple Sclerosis
Completed NCT03591809 - Combined Exercise Training in Patients With Multiple Sclerosis N/A
Completed NCT02845635 - MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis